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The results of investigation of the antiepileptic activity of promising herbal anticonvulsants – Fumaria 
schleicheri (FSDE) and Ocimum basilicum (OBDE) dry extracts – are presented. The herbal remedies 
were administered intragastrically in the conditionally effective dose of 100 mg/kg in the therapeutic 
and preventive mode during 3 days with the last time of 30 minutes before the experiments. As refe­
rence drugs sodium valproate and carbamazepine were chosen. Under the conditions of maximal 
electroshock (MES) test the ability of the chosen dry extracts to prevent the development of primarily 
generalized convulsions was studied. For the in­depth study of antiepileptic properties of FSDE and 
OBDE the model of pentylenetetrazole (corasole)­induced kindling has been chosen. In general the 
researched dry extracts in the condition of the MES test have shown the anticonvulsant effect on the 
level of sodium valproate, but they were slightly inferior in efficacy compared with carbamazepine. 
On the model of pentylenetetrazole­induced kindling it has been shown that FSDE unlike OBDE and 
sodium valproate has the ability to prevent convulsions under the conditions of experimental chronic 
epileptogenesis. Thus, it has been found that OBDE is able to prevent the development of primary 
generalized seizures, while FSDE prevents acute paroxysms stimulated by electrical impulse and 
chronic epileptogenesis.
Under conditions of progressing development and 
spreading of nervous and psychic diseases the problem 
of improving the quality of treating epilepsy is topical. 
According to the data of the WHO almost 0.68 per cent 
of the world population suffers from this disease and 
this figure has been increasing steadily [11]. It is well 
known that treating chronic diseases, including epilepsy, 
is a rather long-term if not lifelong process [3]. That is 
why in this case the use of herbal medicines is relevant 
as they are highly safe even in the situation of a long-
term application [12]. 
In the previous studies on different models of chemo- 
induced convulsions, including those caused by penty- 
lenetetrazole (the main screening model [1]), picrotoxin, 
thiosemicarbazide, strychnine and camphor, the high level 
of anticonvulsant properties was shown by the dry ex-
tract of fumitory (Fumaria schleicheri Soy.-Willem., 
Fumariaceae) and the dry extract of basil (Ocimum ba- 
silicum L., Lamiaceae) [7, 8]. Taking into account the 
absence of herbal medicines with the proven anticon-
vulsant activity at the domestic and international phar-
maceutical markets the profound study of the antiepi-
leptic properties of these dry extracts is reasonable.  
The aim of this work is to study the antiepileptic 
potential of the promising herbal anticonvulsant drugs 
– dry extracts of Fumaria schleicheri (FSDE) and Oci- 
mum basilicum (OBDE) obtained from the aerial part 
of the plants according to the requirements of the State 
Pharmacopoeia of Ukraine – taking into consideration 
their ability to prevent primarily generalized convulsions 
on the model of seizures induced by the maximal elec-
troshock and the ability to inhibit epileptogenesis under 
conditions of pentylenetetrazole-induced kindling. 
Materials and Methods 
The experimental part was performed on 86 white 
random-bred mice. The animals were kept in the stan-
dard conditions of the vivarium of the Central Research 
Laboratory at the National University of Pharmacy ac- 
cording to the hygiene norms and principles of the Euro- 
pean Convention on laboratory animals protection (Stras- 
bourg, 1986). In the research period the animals were 
kept in the vivarium at the temperature of 19-24°С, with 
humidity of not more than 50%, in the “day-night” natu- 
ral light mode in plastic cages with the standard nutri- 
tion and free access to water and food. All research pro-
cesses were performed according to the “General ethi-
cal principles of the experiments with animals” [6] and 
according to the methodological recommendations for 
pre-clinical study of specific activity of potential anti-
convulsant medicines [1]. 
In the conditions of maximal electroshock (MES) test 
the ability of the chosen dry extracts to prevent the deve-
lopment of primarily generalized convulsions was studied 
[1]. The experiments were conducted on 55 random-
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bred male albino mice with the body weight of 21-27 g 
that were randomly divided into 5 groups: 1 – control; 
2-3 – the groups where animals received aqueous solu-
tions of the given dry extracts; 4-5 – comparison groups 
where animals received reference drugs such as sodium 
valproate and carbamazepine. The reference drugs were 
chosen taking into account the recommendations [1, 4]. 
The dry extracts studied were obtained by Yu.S.Pro- 
kopenko, the assistant of the Department of Quality, Stan- 
dardization and Certification of Medicines, the Institute 
of Pharmacy Professionals Qualification Improvement 
at the National University of Pharmacy. The aerial parts 
of Fumaria schleicheri Soy.-Willem. and Ocimum ba- 
silicum L. were collected in the phase of blooming in dif-
ferent regions of Ukraine (Kharkiv, Luhansk, Donetsk, 
Ternopil, Rivne, Zhytomyr, Kyiv regions and the Re-
public of Crimea). The raw material was washed with 
water and air-dried. The dried material was kept at the 
room temperature. A relatively dry herbal material was 
powdered and extracted with distilled water (1:10) for 
2 hours at the temperature of 80°C. The process was 
repeated 3-4 times up to the full extraction of the bio-
logically active substances from the raw material. The 
received extracts were mixed, filtered and concentrated 
in vacuum device at the temperature of 50-60 °C and 
the pressure of 80-87 kPa up to thick consistency. The 
received semi-product was dried in vacuum-drying de-
vice up to the remaining humidity of 5% [5].
FSDE was standardized according to the content of 
alkaloids (the noscapine group) and flavonoids (flavo-
noles and flavons) using the method of absorption UV-
spectrophotometery [5], and OBDE – according to the 
content of flavonoids. 
The animals of experimental group received intra-
gastically the aqueous solutions of the given dry extracts 
in the conditionally effective dose 100 mg/kg [7] in the 
treating and preventive mode during 3 days with the last 
time 30 minutes before conducting the experiment. The 
comparison groups received intragastically classic antie-
pileptic medicines – sodium valproate (the syrup “Depa-
kine”, Sanofi-Aventis, France) in the dose of 300 mg/kg 
and carbamazepine (“Finlepsin”, TEVA, Israel/Poland) 
in the dose of 40 mg/kg in the same mode. The second 
reference drug was injected in the form of a thin aque-
ous suspension solubilized by Tween-80. The mice in 
the control group received intragastically distilled wa-
ter (0.1 ml per 10 g of the body weight).
Then the animals through the corneal electrodes were 
affected by electric stimuli with duration of 0.2 sec, fre-
quency of 50 Hz and current of 50 mA. Under these 
conditions 100% of animals in the control group had 
maximum tonic extension of hind limbs. The anticon-
vulsant action was estimated according to the following 
indicators: duration of convulsions, the time of the sur-
vived mice recovery, the time of the animals’ death and 
the percentage of lethality in the experimental groups [4].
For the profound study of antiepileptic properties of 
the extracts the model of pentylenetetrazole (corasole)-
induced kindling was chosen [1, 4].
Kindling is a phenomenon based on the occurrence 
of focal convulsion afterdischarge, behavioral automa-
tisms and generalized convulsion attacks in response to 
multiple epileptic stimulations of subthreshold inten-
sity that at first do not cause convulsions. The kindling 
model is characterized with the unique methodological 
advantages for experimental determination of the ef-
fect of potential anticonvulsant drugs on pathophysiol-
ogy of seizures [1, 4]. Under conditions of the kindling 
model one can clearly check the start of convulsions, 
the stages of their development and preserving. Beha- 
vioral patterns in this model are characterized by high 
repeatability, easy visual control of their intensity, seve- 
rity and duration. The kindling model reflects patophy- 
siological and clinical specificities of epilepsy in the most 
adequate way and the phenomenon of “swaying” is viewed 
as an universal mechanism, which takes part in epilepsy 
not only experimentally, but it is also practically char-
acteristic for the human brain [9]. 
For the experiment 31 random-bred albino male mice 
with the body weight of 22-29 g were selected. The 
animals were divided into 4 groups (n=7-9): 1– control; 
2-3 – groups of animals that received aqueous solutions 
of the given dry extracts; 4 – group of comparison that 
received sodium valproate as a reference drug. 
The animals of experimental groups received  intra-
gastically the aqueous solutions of appropriate dry extracts 
in the conditionally therapeutic dose of 100 mg/kg [7] in 
the therapeutic and preventive mode during 27 days once 
a day 30 minutes before injecting the convulsant. The 
group of comparison received intragastically a classic 
anticonvulsant drug sodium valproate (the syrup “Depa-
kine”, Sanofi-Aventis, France) in the dose of 300 mg/kg 
in the same mode. The mice from the control group re-
ceived intragastically distilled water (0.1 ml per 10 g of 
the body weight). The aqueous solution of pentylene-
tetrazole (corasole) was injected intraperitoneally in the 
subthreshold dose of 30 mg/kg.  
After injecting of the convulsant every mouse was 
placed into a separate plastic cylinder box with the di-
ameter of 20 cm and the height of 35 cm. The state of 
every mouse was being observed for 30 min. The an-
ticonvulsant activity was estimated daily according to 
the following indicators: the percentage of mice with 
convulsions in each group, the number of days with 
paroxysms in the group, as well as according to the 
most informative indicator – the day of occurrence of 
the first convulsions in the group [4]. 
The results was expressed as mean ± standard error 
of mean (SEM). Statistical differences between groups 
were analyzed using Student’s t-test (in case of normal 
distribution), Mann-Whitney U test and Fisher angular 
transformation (for the alternative form of analysis). The 
level of statistical significance was considered as р<0.05. 
Results and Discussion 
The maximal electroshock in 100% of animals from 
the control group was followed by immediate develop-
ment of several convulsions in the form of clonic-tonic 
paroxysms with prevailing of the tonic component. The 
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death of 53.3% of mice was caused by the tonic exten-
sion of hind limbs (Table). It corresponds to the existing 
data, which show the variation of the lethality level in 
the wide range from 0 to 100% [10, 13] depending on 
many factors.
In the MES test the herbal drugs studied showed 
marked anticonvulsant properties. FSDE decreased du-
ration of convulsions by 2.1 times compared to control 
(p<0.05), and also decreased the time of recovery of the 
survived animals by 3 times (p>0.05). Such indicators 
as the time of death and the lethality level in the group 
were not seriously influenced by FSDE. 
OBDE decreased duration of the tonic extension of 
hind limbs almost by 2 times compared to the control 
group, but because of the high dispersion of data this 
difference did not reach the level of statistical signifi-
cance. But OBDE significantly decreased the time of 
the mice recovery by more than 10 times compared to 
the indicator in the control group. The positive effect of 
OBDE on the time of death and lethality in the experi-
mental group was not recorded. 
Sodium valproate showed the effect at the level of 
the studied dry extracts – it statistically significantly de-
creased the duration of convulsions compared with the 
control group by 2.3 times and showed the tendency 
to decrease the recovery time by 4.3 times without the 
influence on the death time and lethality level in the 
group.
Carbamazepine showed the most expressed anticon- 
vulsant activity, which significantly exceeded the simi-
lar effect of the studied herbal drugs and sodium valpro-
ate. Under its action not only duration of convulsions, 
but also the recovery time decreased by 11.4 and 11.0 
times, respectively. Besides, carbamazepine completely 
prevented the death of animals (p<0.01).
On the model of pentylenetetrazole-induced kindling 
according to the most informative indicator – the day of 
the first convulsions occurrence – FSDE continued the 
latent period of the first convulsions occurrence with 
statistical significance (Fig. 1): in the control group spon- 
taneous seizures were observed on the 23rd day of the 
study, while FSDE continued the latent period of attack 
occurrence up to the 27th day (p<0.01).
According to the data of Fig. 1 it can also be ob-
served that FSDE decreased the percentage of mice with 
convulsions in the group from the 23rd to the 27th day, 
Table
The effect of Fumaria schleicheri and Ocimum basilicum dry extracts, sodium valproate  
and carbamazepine on the seizures induced by the maximal electroshock in mice (M±m)






of death, sec Lethality, %
Control – 15 19.40±3.66 18.71±7.89 20.00±1.85 53.3
FSDE 100 10 9.20±2.28*/** 6.14±1.68** 16.33±4.70 30*****
OBDE 100 10 9.88±3.47** 1.83±0.98*# 21.75±2.93 40*****
Sodium valproate 300 10 8.60±2.37*/** 4.29±0.47** 18.67±3.18 30*****
Carbamazepine 40 10 1.70±1.07****# 1.70±1.07* – 0***
Note: 1. Statistically significant differences: * – compared to control (p<0.05); ** – compared to the group receiving carbamazepine (p<0.05);  
*** – compared to control (p<0.01); **** – compared to control (p<0.001); ***** – compared to the group receiving carbamazepine (p<0.01);  
# – compared to the group receiving sodium valproate (p<0.05).  
2. Abbrevations: FSDE – Fumaria Schleicheri dry extract; OBDE – Ocimum Basilicum dry extract.
Fig. 1. Dynamics of the anticonvulsant activity of Fumaria schleicheri and Ocimum basilicum dry extracts 
and sodium valproate under conditions of pentylenetetrazole-induced kindling. 
Note: * – statistically significant difference compared to control (p<0.05).
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including the last one (p<0.05), while OBDE at the same 
dose decreased the corresponding indicator only on the 
23rd and the 27th days. The reference drug sodium val-
proate on this model showed relatively weak antiepi-
leptic properties: significant decrease of the percentage of 
mice with convulsions was observed only on the 27th day 
of the study. Besides, in the groups where animals received 
OBDE and sodium valproate no increase of the latent 
period of spontaneous seizures occurrence was observed. 
As can be seen from the data of Fig. 2, only FSDE 
significantly decreased the total number of days with con-
vulsions compared to control (p<0.01). Neither OBDE, 
nor sodium valproate affected this indicator under the 
same conditions. 
As it is known, the anticonvulsant properties are cha- 
racteristic to combinations of different chemical com-
pounds [2, 12]. However, most representatives with the 
above-mentioned pharmacological activity belong to such 
classes of biologically active substances as flavonoids, 
alkaloids, as well as terpenes and volatile components 
of essential oils [2]. The role of individual components 
and fractions of FSDE and OBDE in providing the an-
ticonvulsive effect requires further verification and is a 
subject of the next research stage. 
CONCLUSIONS
1. The antiepileptic properties of Fumaria schlei- 
cheri dry extract (FSDE) and Ocimum basilicum dry 
extract (OBDE) have been studied. 
2. Under conditions of the maximal electroshock test 
it has been found that FSDE and OBDE in the dose of 
100 mg/kg showed considerable anticonvulsant proper-
ties that were not inferior to the effect of sodium valpro-
ate in the dose of 300 mg/kg, but did not reach the level 
of carbamazepine in the dose of 40 mg/kg. 
3. On the model of pentylenetetrazole-induced kin-
dling it has been shown that FSDE unlike OBDE and 
sodium valproate has the ability to prevent convulsions 
under conditions of the experimental chronic epilepto-
genesis. 
4. The obtained data allow recommending FSDE for 
further research with the aim of developing the first Ukrai-
nian herbal antiepileptic drug. 
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ПРОТИЕПІЛЕПТИЧНИЙ ПОТЕНЦІАЛ СУХИХ ЕКСТРАКТІВ РУТКИ ШЛЕЙХЕРА ТА БАЗИЛІКУ 
КАМФОРНОГО
В.В.Цивунін, С.Ю.Штриголь
Ключові слова: лікарські рослини; екстракти; протиепілептичні засоби
В роботі представлені результати дослідження протиепілептичної активності перспек­
тивних рослинних антиконвульсантів – сухих екстрактів рутки Шлейхера (СЕРШ) та бази­
ліку камфорного (СЕБК). Рослинні препарати вводили внутрішньошлунково в умовно ефек­
тивній дозі 100 мг/кг у лікувально-профілактичному режимі протягом трьох днів, востаннє 
за 30 хв до експерименту. В якості препаратів порівняння було обрано натрію вальпроат 
та карбамазепін. За умов тесту максимального електрошоку (МЕШ) вивчали здатність об­
раних сухих екстрактів запобігати розвитку первинно-генералізованих судом. Для погли­
бленого дослідження протиепілептичних властивостей СЕРШ та СЕБК було обрано модель 
пентилентетразолового (коразолового) кіндлінгу. Загалом досліджувані сухі екстракти за 
умов тесту МЕШ виявили виразний протисудомний ефект на рівні натрію вальпроату, про­
те поступалися за ефективністю карбамазепіну. На моделі пентилентетразолового кінд­
лінгу було встановлено, що СЕРШ, на відміну від СЕБК та натрію вальпроату, має здатність 
запобігати розвитку судом за умов експериментального хронічного епілептогенезу. Отже, 
встановлено, що СЕБК виявляє антиконвульсивну активність на моделі первинно-генера­
лізованих судом, у той час як СЕРШ запобігає розвитку як гострих електростимульованих 
пароксизмів, так і хронічного епілептогенезу. 
ПРОТИВОЭПИЛЕПТИЧЕСКИЙ ПОТЕНЦИАЛ СУХИХ ЭКСТРАКТОВ ДЫМЯНКИ ШЛЕЙХЕРА 
И БАЗИЛИКА КАМФОРНОГО 
В.В.Цывунин, С.Ю.Штрыголь
Ключевые слова: лекарственные растения; экстракты; противоэпилептические 
средства
В работе представлены результаты исследования противоэпилептической активности 
перспективных растительных антиконвульсантов – сухих экстрактов дымянки Шлейхера 
(СЭДШ) и базилика камфорного (СЭБК). Растительные препараты вводили внутрижелудоч­
но в условно эффективной дозе 100 мг/кг в лечебно-профилактическом режиме в течение 
трех дней, в последний раз за 30 мин до эксперимента. В качестве препаратов сравнения 
выбраны натрия вальпроат и карбамазепин. В условиях теста максимального электрошо­
ка (МЭШ) изучали способность исследуемых сухих экстрактов предотвращать развитие 
первично-генерализованных судорог. Для углубленного изучения противоэпилептических 
свойств СЭДШ и СЭБК выбрана модель пентилентетразолового (коразолового) киндлин­
га. В целом исследуемые сухие экстракты в условиях теста МЭШ выявили значительный 
противосудорожный эффект на уровне натрия вальпроата, однако уступали по эффек­
тивности карбамазепину. На модели пентилентетразолового киндлинга было установле­
но, что СЭДШ, в отличие от СЭБК и натрия вальпроата, имеет свойство предотвращать 
развитие судорог в условиях экспериментального хронического эпилептогенеза. Итак, 
установлено, что СЭБК оказывает антиконвульсивную активность на модели первично-ге­
нерализованых судорог, в то время как СЭДШ предотвращает развитие как острых элек­
тростимулируемых пароксизмов, так и хронического эпилептогенеза.
